Blackstone (BX.N) is exploring a sale of medical-grade skincare brand ZO Skin Health at a roughly $2 billion valuation, signaling renewed private-equity appetite for clinically backed consumer health assets.
A deal at that figure would underscore how strongly strategic buyers...